Identification of anti-retinal antibodies in patients with age-related macular degeneration

Experimental and Molecular Pathology

Volumn 93, Issue 2, 2012, Pages 193-199

  Morohoshi, Kei ^a,b,c   Ohbayashi, Masaharu ^b   Patel, Nishal ^d   Chong, Victor ^e   Bird, Alan C ^f   Ono, Santa J ^b,c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Age related macular degeneration; Aldolase; Anti retinal antibody; Autoantibody profile; Pyruvate kinase

Indexed keywords

ALDOLASE C; AUTOANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PYRUVATE KINASE; PYRUVATE KINASE M2; RETINA ANTIBODY; RETINOL BINDING PROTEIN; RETINOL BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPARATION TECHNIQUE; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GEOGRAPHIC ATROPHY; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; PROGNOSIS; PYRUVATE KINASE; RETINA; RETINOL-BINDING PROTEINS; WET MACULAR DEGENERATION;

EID: 84862170636     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.03.007     Document Type: Article

References (35)

1. Ahn B.Y., Song E.S., Cho Y.J., Kwon O.W., Kim J.K., Lee N.G. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Proteomics 2006, 6:1200-1209.
2. Ambati J., Ambati B.K., Yoo S.H., Ianchulev S., Adamis A.P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Survey of Ophthalmology 2003, 48:257-293.
3. Ashizawa K., Willingham M.C., Liang C.M., Cheng S.Y. In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. The Journal of Biological Chemistry 1991, 266:16842-16846.
4. Avichezer D., Silver P.B., Chan C.C., Wiggert B., Caspi R.R. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Investigative Ophthalmology & Visual Science 2000, 41:127-131.
5. Braus B.K., Hauck S.M., Amann B., Heinrich C., Fritsche J., Kostlin R., Deeg C.A. Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome. Veterinary Immunology and Immunopathology 2008, 124:177-183.
6. Butterfield D.A., Poon H.F., St Clair D., Keller J.N., Pierce W.M., Klein J.B., Markesbery W.R. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiology of Disease 2006, 22:223-232.
7. Caffe A.R., Von Schantz M., Szel A., Voogd J., Van Veen T. Distribution of Purkinje cell-specific Zebrin-II/aldolase C immunoreactivity in the mouse, rat, rabbit, and human retina. The Journal of Comparative Neurology 1994, 348:291-297.
8. Cano, M., Thimmalappula, R., Fujihara, M., Nagai, N., Sporn, M., Wang, A.L., Neufeld, A.H., Biswal, S., Handa, J.T., Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration. Vision Research 50, 652-64.
9. Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris F.L. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 2005, 112:533-539.
10. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14682-14687.
11. Deeg C.A., Raith A.J., Amann B., Crabb J.W., Thurau S.R., Hauck S.M., Ueffing M., Wildner G., Stangassinger M. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clinical & Developmental Immunology 2007, 2007:39245.
12. Donoso L.A., Kim D., Frost A., Callahan A., Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 2006, 51:137-152.
13. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
14. Gu X., Meer S.G., Miyagi M., Rayborn M.E., Hollyfield J.G., Crabb J.W., Salomon R.G. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. The Journal of Biological Chemistry 2003, 278:42027-42035.
15. Gu J., Pauer G.J., Yue X., Narendra U., Sturgill G.M., Bena J., Gu X., Peachey N.S., Salomon R.G., Hagstrom S.A., Crabb J.W. Proteomic and genomic biomarkers for age-related macular degeneration. Advances in Experimental Medicine and Biology 2010, 664:411-417.
16. Gupta V., Bamezai R.N. Human pyruvate kinase M2: a multifunctional protein. Protein Science 2010, 19:2031-2044.
17. Heckenlively J.R., Jordan B.L., Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. American Journal of Ophthalmology 1999, 127:565-573.
18. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nature Medicine 2008, 14:194-198.
19. Jager R.D., Mieler W.F., Miller J.W. Age-related macular degeneration. The New England Journal of Medicine 2008, 358:2606-2617.
20. Joachim S.C., Bruns K., Lackner K.J., Pfeiffer N., Grus F.H. Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 2006.
21. Kaarniranta K., Salminen A., Haapasalo A., Soininen H., Hiltunen M. Age-related macular degeneration (AMD): Alzheimer's disease in the eye?. Journal of Alzheimer's Disease 2011, 24:615-631.
22. Liao W.L., Turko I.V. Accumulation of large protein fragments in prematurely senescent ARPE-19 cells. Investigative Ophthalmology & Visual Science 2009, 50:4992-4997.
23. Mamczur P., Mazurek J., Rakus D. Ubiquitous presence of gluconeogenic regulatory enzyme, fructose-1,6-bisphosphatase, within layers of rat retina. Cell and Tissue Research 2011, 341:213-221.
24. Morohoshi K., Goodwin A.M., Ohbayashi M., Ono S.J. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. Journal of Autoimmunity 2009, 33:247-254.
25. Morohoshi K., Patel N., Ohbayashi M., Chong V., Grossniklaus H.E., Bird A.C., Ono S.J. Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Experimental and Molecular Pathology 2011, 92:64-73.
26. Ohguro H., Yokoi Y., Ohguro I., Mamiya K., Ishikawa F., Yamazaki H., Metoki T., Takano Y., Ito T., Nakazawa M. Clinical and immunologic aspects of cancer-associated retinopathy. American Journal of Ophthalmology 2004, 137:1117-1119.
27. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Progress in Retinal and Eye Research 2011, 30:217-238.
28. Patel N., Ohbayashi M., Nugent A.K., Ramchand K., Toda M., Chau K.Y., Bunce C., Webster A., Bird A.C., Ono S.J., Chong V. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005, 115:422-430.
29. Perluigi M., Di Domenico F., Giorgi A., Schinina M.E., Coccia R., Cini C., Bellia F., Cambria M.T., Cornelius C., Butterfield D.A., Calabrese V. Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. Journal of Neuroscience Research 2010, 88:3498-3507.
30. Rein D.B., Wittenborn J.S., Zhang X., Honeycutt A.A., Lesesne S.B., Saaddine J. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Archives of Ophthalmology 2009, 127:533-540.
31. Seddon J.M., Ajani U.A., Mitchell B.D. Familial aggregation of age-related maculopathy. American Journal of Ophthalmology 1997, 123:199-206.
32. Stetak A., Veress R., Ovadi J., Csermely P., Keri G., Ullrich A. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Research 2007, 67:1602-1608.
33. Tanito M., Haniu H., Elliott M.H., Singh A.K., Matsumoto H., Anderson R.E. Identification of 4-hydroxynonenal-modified retinal proteins induced by photooxidative stress prior to retinal degeneration. Free Radical Biology & Medicine 2006, 41:1847-1859.
34. Thornton J., Edwards R., Mitchell P., Harrison R.A., Buchan I., Kelly S.P. Smoking and age-related macular degeneration: a review of association. Eye 2005, 19:935-944.
35. Umeda S., Suzuki M.T., Okamoto H., Ono F., Mizota A., Terao K., Yoshikawa Y., Tanaka Y., Iwata T. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). The FASEB Journal 2005, 19:1683-1685.